Advertisement
News
Subscribe to MDT Magazine News

For the Treatment of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin as the Standard Second-Line Treatment for Platinum Sensiti...

December 8, 2010 4:33 am | by Bio-Medicine.Org | Comments

BURLINGTON, Mass., Dec. 8, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of...

TOPICS:

Government Regulation of Drug Prices will Increase in Both Mature and Emerging Markets, Including Markets that Traditionally Play a Limited Role in Pharmaceutical Pricing

December 8, 2010 4:33 am | by Bio-Medicine.Org | Comments

BURLINGTON, Mass., Dec. 8, 2010 /- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the pharmaceutical industry must prepare itself for an increasingly draconian drug pricing environment. While governments in...

TOPICS:

Otonomy Appoints David A. Weber, Ph.D., Chief Executive Officer

December 8, 2010 4:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Dec. 8, 2010 /- Otonomy, Inc . announced today that David A. Weber, Ph.D. , has joined the company as president, CEO and member of the Board of Directors. Jay Lichter, Ph.D., managing director of Avalon Ventures, co-founder of Otonomy and CEO since its inception, will continue...

TOPICS:
Advertisement

CareFusion Launches Respiratory Airway Adapter to Improve Patient Safety and Reduce Hospital Costs

December 8, 2010 4:32 am | by Bio-Medicine.Org | Comments

SAN DIEGO, Dec. 8, 2010 /- CareFusion (NYSE: CFN ), a leading, global medical device company, today announced the launch of Verso™ 90 adapter, a component that enables uninterrupted access to a ventilated patient's airway without having to disconnect the patient from the ventilator....

TOPICS:

Texas-Based Healthcare Delivery System Expands Utilization of Streamline Health Document Workflow Solutions

December 8, 2010 4:32 am | by Bio-Medicine.Org | Comments

CINCINNATI, Dec. 8, 2010 /- Streamline Health Solutions, Inc. (Nasdaq: STRM ), a leading provider of document workflow solutions for hospitals, today announced that one of the largest faith-based, nonprofit healthcare delivery systems in the United States, will implement Streamline...

TOPICS:

Winner Medical Reports Fourth Quarter and Fiscal 2010 Results

December 8, 2010 4:32 am | by Bio-Medicine.Org | Comments

SHENZHEN, China, Dec. 8, 2010 /PRNewswire-Asia-FirstCall/ -- Fourth - Quarter 2010 Highlights Revenue increased by 2.1% over Q4 FY09 to $28.2 million Gross profit increased by 5.8% over Q4 FY09 to $8.8 million Net income increased by 5.9% over Q4 FY09 to $3.1 million with EPS of $0.13...

TOPICS:

Sofie Biosciences Raises $2M to Support Development of Diagnostic Imaging Agents and Devices

December 8, 2010 4:32 am | by Bio-Medicine.Org | Comments

CULVER CITY, Calif., Dec. 8, 2010 /- Sofie Biosciences, a developer of agents and devices for the molecular imaging of disease, announced today the closing of an additional $2 million from new and existing investors. Funds will be used for the development of new PET imaging agents and for...

TOPICS:

Life Spine® Announces Completion of Surgeries Utilizing OCTAVE™ Posterior Fusion System

December 8, 2010 4:32 am | by Bio-Medicine.Org | Comments

HOFFMAN ESTATES, Ill., Dec. 8, 2010 /- Life Spine announced today that the company has successfully completed initial cases with the OCTAVE Posterior Fusion System, which is intended for attachment to the spinous processes for the purpose of achieving fusion in conjunction with bone...

TOPICS:
Advertisement

Valeritas Receives FDA 510(k) Clearance for the V-Goâ„¢ Disposable Insulin Delivery Device

December 8, 2010 4:32 am | by Bio-Medicine.Org | Comments

BRIDGEWATER, N.J., Dec. 8, 2010 /- Valeritas, Inc., a medical technology company committed to the development and commercialization of innovative drug delivery solutions, announced today that the US Food and Drug Administration has cleared the company's V-Go Disposable Insulin Delivery...

TOPICS:

World Vaccine Leaders to Meet in New Delhi India to Tackle Global Public Health Challenges

December 8, 2010 3:34 am | by Bio-Medicine.Org | Comments

SINGAPORE, Dec. 8, 2010 /PRNewswire-Asia/ -- From the 1st to the 3rd of March 2011, vaccine leaders from developing and developed world will meet at Vaccine World Summit in New Delhi. The event will be hosted by IMAPAC, in partnership with DCVMN (Developing Countries Vaccine Manufacturers...

TOPICS:

New test shows promise for accurate early diagnosis of Turner syndrome

December 8, 2010 3:33 am | by EurekAlert | Comments

(The Endocrine Society) A recent study accepted for publication in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism has demonstrated a novel and accurate test for early diagnosis of Turner syndrome. Turner syndrome affects one in 1,500 to 2,000 female live births and...

TOPICS:

Carl Zeiss CEO hails "best ever" year

December 8, 2010 12:37 am | by I-Micronews | Comments

With revenues up 42% on 2009 and an even stronger ramp in orders, the diverse German photonics group has a new chief and is in buoyant mood.

Pure nanotube-type growth edges toward the possible.

December 8, 2010 12:37 am | by I-Micronews | Comments

In calculating energies for graphene, Rice researchers find clues to chiral control.

EMCORE enters into agreement to establish its Suncore joint venture in Huainan, China

December 8, 2010 12:37 am | by I-Micronews | Comments

EMCORE Corporation, a leading provider of compound semiconductor-based components, subsystems and systems for the fiber optics and solar power markets, today announced it has entered into an investment and cooperation agreement ("Agreement") with San'an Optoelectronics Company, Limited...

NYSE Amex Accepts China Shenghuo's Compliance Plan for Continued Listing

December 8, 2010 12:36 am | by Bio-Medicine.Org | Comments

KUNMING, China, Dec. 8, 2010 /PRNewswire-Asia-FirstCall/ -- China Shenghuo Pharmaceutical Holdings, Inc. (NYSE Amex Equities: KUN) ("China Shenghuo" or the "Company"), which is engaged in the research, development, manufacture, and marketing of pharmaceutical, nutritional supplement and...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading